Insider Buying: Cerecor Inc. (CERC) Director Purchases 35,200 Shares of Stock

Cerecor Inc. (NASDAQ:CERC) Director Armistice Capital, Llc bought 35,200 shares of the firm’s stock in a transaction dated Wednesday, November 22nd. The shares were purchased at an average price of $1.20 per share, with a total value of $42,240.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Armistice Capital, Llc also recently made the following trade(s):

  • On Friday, November 24th, Armistice Capital, Llc bought 10,000 shares of Cerecor stock. The shares were purchased at an average price of $1.20 per share, with a total value of $12,000.00.
  • On Wednesday, September 20th, Armistice Capital, Llc bought 15,250 shares of Cerecor stock. The shares were purchased at an average price of $0.76 per share, with a total value of $11,590.00.
  • On Tuesday, September 19th, Armistice Capital, Llc bought 30,119 shares of Cerecor stock. The shares were purchased at an average price of $0.74 per share, with a total value of $22,288.06.
  • On Monday, September 18th, Armistice Capital, Llc bought 6,000 shares of Cerecor stock. The shares were purchased at an average price of $0.78 per share, with a total value of $4,680.00.
  • On Friday, September 8th, Armistice Capital, Llc bought 2,060 shares of Cerecor stock. The shares were purchased at an average price of $0.75 per share, with a total value of $1,545.00.
  • On Wednesday, September 6th, Armistice Capital, Llc bought 2,239 shares of Cerecor stock. The shares were purchased at an average price of $0.74 per share, with a total value of $1,656.86.
  • On Friday, September 1st, Armistice Capital, Llc bought 13,867 shares of Cerecor stock. The shares were purchased at an average price of $0.73 per share, with a total value of $10,122.91.
  • On Thursday, August 31st, Armistice Capital, Llc bought 25,100 shares of Cerecor stock. The shares were purchased at an average price of $0.77 per share, with a total value of $19,327.00.
  • On Wednesday, August 30th, Armistice Capital, Llc bought 512 shares of Cerecor stock. The shares were purchased at an average price of $0.74 per share, with a total value of $378.88.

Cerecor Inc. (CERC) traded up $0.01 during midday trading on Friday, reaching $1.18. The company’s stock had a trading volume of 126,600 shares, compared to its average volume of 493,778. The stock has a market cap of $30.74, a PE ratio of 118.00 and a beta of 2.13. Cerecor Inc. has a 52-week low of $0.34 and a 52-week high of $5.60.

ILLEGAL ACTIVITY NOTICE: “Insider Buying: Cerecor Inc. (CERC) Director Purchases 35,200 Shares of Stock” was published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The original version of this piece of content can be accessed at https://www.com-unik.info/2017/11/24/insider-buying-cerecor-inc-cerc-director-purchases-35200-shares-of-stock.html.

A number of analysts have recently issued reports on CERC shares. ValuEngine upgraded Cerecor from a “strong sell” rating to a “sell” rating in a report on Tuesday, November 7th. TheStreet upgraded Cerecor from an “e+” rating to a “c-” rating in a report on Wednesday, November 8th.

Cerecor Company Profile

Cerecor, Inc is a clinical stage biopharmaceutical company. The Company is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The Company has a portfolio of clinical and preclinical compounds that it is developing for a range of indications, including CERC-301, which is an adjunctive treatment for major depressive disorder (MDD); CERC-501, which is for substance use disorders and adjunctive treatment of MDD, and CERC-406, which is for the treatment of cognitive impairment.

Insider Buying and Selling by Quarter for Cerecor (NASDAQ:CERC)

What are top analysts saying about Cerecor Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cerecor Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit